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Persister cells (PCs) are a subset of dormant, phenotypic variants of regular bacteria,
highly tolerant to antibiotics. Generation of PCs in vivo may account for the recalcitrance
of most chronic infections to antimicrobial treatment and demands for the identification
of new antimicrobial agents able to target such cells. The present study explored the
possibility to obtain in vitro PCs of Pseudomonas aeruginosa and Staphylococcus
aureus at high efficiency through chemical treatment, and to test their susceptibility to
structurally different antimicrobial peptides (AMPs) and two clinically used peptide-based
antibiotics, colistin and daptomycin. The main mechanism of action of these molecules
(i.e., membrane-perturbing activity) renders them potential candidates to act against
dormant cells. Exposure of stationary-phase cultures to optimized concentrations of
the uncoupling agent cyanide m-chlorophenylhydrazone (CCCP) was able to generate
at high efficiency PCs exhibiting an antibiotic-tolerant phenotype toward different
classes of antibiotics. The metabolic profile of CCCP-treated bacteria was investigated
by monitoring bacterial heat production through isothermal microcalorimetry and by
evaluating oxidoreductase activity by flow cytometry. CCCP-pretreated bacteria of
both bacterial species underwent a substantial decrease in heat production and
oxidoreductase activity, as compared to the untreated controls. After CCCP removal,
induced persisters showed a delay in heat production that correlated with a lag phase
before resumption of normal growth. The metabolic reactivation of bacteria coincided
with their reversion to an antibiotic-sensitive phenotype. Interestingly, PCs generated by
CCCP treatment resulted highly sensitive to three different membrane-targeting AMPs
at levels comparable to those of CCCP-untreated bacteria. Colistin was also highly
active against PCs of P. aeruginosa, while daptomycin killed PCs of S. aureus only
at concentrations 32 to 64-fold higher than those of the tested AMPs. In conclusion,
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CCCP treatment was demonstrated to be a suitable method to generate in vitro PCs of
medically important bacterial species at high efficiency. Importantly, unlike conventional
antibiotics, structurally different AMPs were able to eradicate PCs suggesting that such
molecules might represent valid templates for the development of new antimicrobials
active against persisters.
Keywords: persisters, induction of persistence, Staphylococcus aureus, Pseudomonas aeruginosa, isothermal
microcalorimetry, antimicrobial peptides
INTRODUCTION
Within an isogenic bacterial population, PCs comprise a
small subpopulation of non-growing, metabolically quiescent
cells that exhibit high tolerance to antibiotics (Keren et al.,
2004; Lewis, 2010). Unlike drug-resistant bacteria, PCs survive
antibiotic treatments by reducing their metabolism and entering
into a dormant state without undergoing genetic changes.
Consequently, they do not proliferate in the presence of
antibiotics, but they resume growth after the removal of the
drug, giving rise to a population genetically identical to the
original one and equally susceptible to antibiotics (Balaban
et al., 2004; Kwan et al., 2013). Although PCs can arise from
stochastic events in growing cultures (Maisonneuve et al., 2013),
evidence suggests that their formation can also be induced as
a response to several environmental factors, such as nutrients
and oxygen deprivation, oxidative stress, DNA damage and
antibiotics (Dörr et al., 2009; Wang et al., 2017). For instance,
persister levels typically increase from exponential-phase cultures
to stationary-phase cultures and biofilms, where PCs comprise
as much as 1% of the total bacterial population (Lewis,
2008).
Persister cells represent a major challenge for the treatment
of many types of infections. As they are present in significant
number in biofilms, it is believed that they largely contribute to
the recalcitrance to antibiotic treatment and chronicization of
biofilm-associated infections (e.g., urinary tract infections, lung
infections in cystic fibrosis, medical device-associated infections)
(Lewis, 2008; Conlon, 2014). Indeed, while antibiotic treatment
leads to the elimination of most of the biofilm-susceptible
population, a small fraction of phenotypic persister variants
survives. Once the antibiotic therapy is suspended, residual
PCs resume growth and allow for the recolonization of the
infection site, precluding the eradication of the infection (Lewis,
2001; Levin and Rozen, 2006). As the elimination of PCs seems
crucial to improve the management of chronic biofilm-associated
infections, the development of novel antimicrobial agents able to
target such cells is emerging as a research priority (Conlon et al.,
2013; Zhang, 2014).
The low frequency of PCs and their transient nature make
it difficult to isolate the persister population from bacterial
cultures, thereby representing a substantial limitation for the
Abbreviations: AMP, antimicrobial peptide; CCCP, carbonyl cyanide
m-chlorophenylhydrazone; CFU, colony-forming units; DMSO, dimethyl
sulfoxide; LB, Luria-Bertani Broth; MBC, minimal bactericidal concentration;
MIC, minimal inhibitory concentration; PC, persister cell; RSG, redox sensor
green; SPB, sodium-phosphate buffer; TSA, tryptone soy agar.
study of persistence and the identification of anti-persister
molecules (Cañas-Duarte et al., 2014). Recent studies have
demonstrated the possibility to obtain bacterial populations with
high levels of PCs through chemical treatments. In particular,
Kwan et al. (2013) have found that the uncoupling agent
CCCP is able to efficiently induce persistence in cultures of
Escherichia coli. CCCP has been reported to decrease ATP
production by bacterial ATPases through the dissipation of
the proton motive force, thereby leading to a drop in cell
metabolic activity (Strahl and Hamoen, 2010). Although multiple
mechanisms underlie persister formation, reduction in ATP
levels has been lately proposed as a universal cause of multidrug
tolerance in bacteria since the activity of most bactericidal
antibiotics is directed toward targets expressed by metabolically
active cells (Conlon et al., 2016; Shan et al., 2017). The
majority of research on persisters has been concentrated on
the model organism E. coli, but it is widely recognized that
many other medically relevant bacterial species may produce
PCs (Moker et al., 2010; Keren et al., 2011; Lechner et al.,
2012; Slattery et al., 2013). Aims of the present study were:
(i) evaluate the ability of CCCP to induce persistence in
cultures of Staphylococcus aureus and Pseudomonas aeruginosa,
two bacterial species commonly implicated in relapsing and
chronic infections; (ii) characterize the metabolic activity and
the susceptibility to conventional antibiotics of CCCP-treated
bacteria; (iii) investigate the susceptibility of CCCP-induced
persisters to different membrane-targeting agents, including
colistin, daptomycin and three structurally diverse AMPs.
These included an optimized α-helical analog of temporin
1Tb (TB_L1FK) (Grassi et al., 2017), a β-sheet chimeric
derivative of β-defensins (C5) (Jung et al., 2011) and a semi-
synthetic dendrimeric peptide (Den-SB056) (Batoni et al., 2016).
Indeed, since their main mechanism of action involves the
permeabilization of bacterial membranes, AMPs are likely to
exert a bactericidal activity also against metabolically dormant
cells, thus emerging as promising candidates for the development
of novel anti-persister drugs (Briers et al., 2014). Exposure to
optimized concentrations of CCCP significantly increased the
tolerance of S. aureus and P. aeruginosa to different classes
of antibiotics and determined a global reduction in bacterial
metabolic activity. The high antibiotic tolerance and reduction in
metabolism, along with the reversion to a normal-growing and
antibiotic-sensitive phenotype after CCCP removal, confirmed
the development of the persister status in CCCP-treated cultures.
Interestingly, CCCP-induced persisters of both bacterial species
were susceptible to all tested AMPs at levels comparable to
those of CCCP-untreated bacteria. Colistin was also quite
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active against persisters of P. aeruginosa, while daptomycin
killed persisters of S. aureus only at high concentrations.
Overall, CCCP treatment resulted to be a suitable method
to induce persistence at high efficiency in medically relevant
Gram-positive and Gram-negative bacteria and a useful tool
to evaluate the anti-persister properties of novel antimicrobials.
Unlike most conventional antibiotics, AMPs were able to kill
PCs highlighting their potential employment as anti-persisters
drugs.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
The reference laboratory strains Pseudomonas aeruginosa ATCC
27853 and Staphylococcus aureus ATCC 33591 were used in
the study. Bacteria were grown in Luria-Bertani (LB) medium
(Sigma-Aldrich, St. Louis, MO, United States) at 37◦C with
shaking for liquid cultures and on TSA (Oxoid, Basingstoke,
United Kingdom) plates at 37◦C for enumeration of colony
forming units (CFU).
Carbonyl Cyanide
m-Chlorophenylhydrazone
Carbonyl cyanide m-chlorophenylhydrazone was purchased
from Sigma-Aldrich. CCCP was diluted in DMSO to obtain a
stock solution of 40 mg/mL and stored in aliquots at−20◦C.
Antibiotics
Ciprofloxacin, colistin, levofloxacin and meropenem were
provided as purified powder by the manufacturer (Sigma–
Aldrich). Daptomycin (Cubicin) was purchased as purified
powder from Novartis (Basel, Switzerland). Gentamicin was
supplied as a 10-mg/mL sterile solution by Sigma–Aldrich.
A stock solution of 4 mg/mL of each antibiotic was prepared in
sterile milli-Q water and stored in aliquots at−20◦C.
Antimicrobial Peptides
C5 and TB_L1FK were synthesized by Proteogenix (Schiltigheim,
France). Den-SB056 was provided by PolyPeptide (Limhamn,
Sweden). Analysis of synthetic peptides by high performance
chromatography (HPLC) and mass spectrometry revealed purity
≥98%. Peptides were diluted in milli-Q water to obtain a
stock solution of 1 mM and stored at −80◦C. The main
physicochemical features of the peptides are shown in Table 1.
TABLE 1 | Main structural and physicochemical features of AMPs used in the
study.
Peptide Sequence Molecular weight Charge
C5 GIINTLQKYYCRVRGAICHPVFC 5382.84 +15
PRRYKQIGKCSTRGRKCCRRKK
Den-SB056 [WKKIRVRLSA]2-K-8Aoc-NH2a 2749.76 +10
TB_L1FK FLPIVGLLKSLLK-NH2 1440.86 +3
a8-Aoc is 8-aminooctanoic acid, which is amidated in the peptide construct.
Evaluation of the Effect of CCCP on Cell
Viability
The susceptibility of stationary-phase cultures of P. aeruginosa
and S. aureus to CCCP was determined. Bacteria were grown
in LB medium for approximately 18 h at 37◦C to obtain
stationary-phase cells, as assessed by monitoring bacterial growth
by optical density. A volume of 1 mL of the overnight cultures was
incubated with 10 µL of CCCP at different concentrations (from
25 to 400 µg/mL) for 3 h at 37◦C with shaking. Bacterial cultures
exposed to DMSO were used as cell viability control. Following
the incubation, bacteria were washed twice in sodium-phosphate
buffer (10 mM SPB, pH 7.4) by centrifugation (1700 × g for
10 min), subsequently diluted 10-fold in LB and plated on TSA
to determine the number of CFU.
Induction of Persistence with CCCP
Concentration of CCCP and exposure time able to efficiently
induce persistence in stationary-phase cultures of P. aeruginosa
and S. aureus were investigated. Overnight cultures of
P. aeruginosa and S. aureus were incubated with different
concentrations of CCCP (from 25 to 400 µg/mL) for
1 or 3 h at 37◦C with shaking. The number of CCCP-
induced persisters was determined based on their survival
to antibiotic treatments (Kwan et al., 2013). To this end,
after the pretreatment with CCCP, bacteria were washed
twice in SPB (1700 × g for 10 min) and re-suspended in
SPB/LB (SPB supplemented with 1% LB) at a final density of
1 × 106 CFU/mL. Hence, bacterial suspensions were exposed
to different antibiotics for 3 h: ciprofloxacin (5 µg/mL) or
meropenem (10 µg/mL) in the case of P. aeruginosa and
levofloxacin (2.5 µg/mL) or gentamicin (10 µg/mL) in the
case of S. aureus. CCCP-untreated and CCCP-pretreated
bacteria re-suspended in SPB/LB alone were used as cell
viability controls. The antibiotic concentrations used in the
experiments were chosen based on preliminary assays in which
stationary-phase cultures of P. aeruginosa and S. aureus were
treated with increasing concentrations of each antibiotic.
The threshold concentrations at which a killing plateau was
reached and only spontaneous PCs survived were used for
the experiments (Fauvart et al., 2011). Exposure of CCCP-
pretreated cells to antibiotics was performed in SPB/LB in
order to avoid their metabolic reactivation and replication
after CCCP removal. Following the antibiotic treatment,
bacteria were plated on TSA and the number of surviving PCs
was determined by CFU counting after 48 h of incubation
at 37◦C.
Isothermal Microcalorimetry Assay
The metabolic profile of CCCP-induced persisters of
P. aeruginosa and S. aureus was evaluated by real-time
monitoring of bacterial heat production through isothermal
microcalorimetry. A 48-channel isothermal microcalorimeter
(Thermal Activity Monitor, Model 3102 TAM III, TA
Instruments, New Castle, DE, United States) was used for
the study. Microcalorimetry glass ampoules were aseptically
filled with 1 mL of the stationary-phase cultures and 10 µL
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of CCCP at a final concentration of 200 and 400 µg/mL
for P. aeruginosa and S. aureus, respectively. Ampoules
were inserted into the calorimeter, placed in the thermal
equilibration position for 15 min and then lowered into
the measuring position. After 45 min of signal stabilization,
measurements of the heat flow were initiated and recorded
for 24 h. Data analysis was performed with the manufacturer
software (TAM Assistant) and GraphPad Prism (GraphPad
Software, La Jolla, CA, United States), and results were plotted
as heat flow (in microwatts) or total heat (in joules) versus
time.
Flow Cytometry Assay
The metabolic activity of CCCP-induced PCs of P. aeruginosa
and S. aureus was also evaluated by determining the
oxidoreductase activity through flow cytometry. Stationary-
phase cultures were incubated with CCCP at 200 and 400 µg/mL
for P. aeruginosa and S. aureus, respectively. After a 3-h exposure,
bacteria were washed twice in SPB (1700 × g for 10 min) and
diluted to reach a cell density of 1× 106 CFU/mL. Then, bacterial
suspensions were stained with the RedoxSensorTM Green reagent
(RSG) (BacLightTM RedoxSensorTM Green Vitality Kit, Thermo
Fisher Scientific, Waltham, MA, United States) according to
the manufacturer’s instructions. Briefly, 1 mL of the bacterial
suspension was incubated with 1 µL (P. aeruginosa) or 0.1 µL
(S. aureus) of 1 mM RSG for 10 min at 37◦C in the dark. Stained
samples were analyzed with a BD Accuri C6 flow cytometer (BD
Biosciences, Mountain View, CA, United States) equipped with a
488 nm laser and a 533/30 nm optical filter. Data were collected
and analyzed with BD Accuri C6 software (BD Biosciences),
and results were plotted as cell counts versus fluorescence
intensity.
Revival Assay of CCCP-Induced
Persisters
The time required for the revival of CCCP-induced persisters
was determined by evaluating bacterial heat production and
bacterial growth after the removal of CCCP. Furthermore, the
susceptibility of CCCP-treated cells to different antibiotics after
the revival was assessed in terms of MIC and MBC values
according to the standard microdilution method and compared
to that of untreated cultures. Briefly, stationary-phase cultures
were incubated for 3 h with CCCP at 200 and 400 µg/mL for
P. aeruginosa and S. aureus, respectively. Following incubation,
bacteria were washed twice in SPB (1700 × g for 10 min) in
order to remove CCCP, re-suspended in fresh LB and diluted
to a final density of 1 × 106 CFU/mL. Microcalorimetry
ampoules were aseptically filled with 1 mL of the bacterial
cultures and heat production was continuously determined for
24 h as previously described. In parallel, bacterial growth was
monitored by measuring the optical density at 600 nm (OD600)
of the bacterial cultures at different incubation times. Once
the early exponential phase of growth was reached (OD600 of
0.5), bacteria were harvested, diluted in LB to a final density
of 1 × 106 CFU/mL and incubated into 96-well microplates
with different concentrations of ciprofloxacin (0.125–2 µg/mL)
or meropenem (2.5–40 µg/mL) in the case of P. aeruginosa
and levofloxacin (0.125–2 µg/mL) or gentamicin (5–80 µg/mL)
in the case of S. aureus. Bacterial cells suspended in LB alone
were used as viability control. MIC values were defined as
the lowest concentration of each antibiotic resulting in the
complete inhibition of visible growth after 24 h of incubation
at 37◦C. For the determination of MBC values, bacteria from
wells that did not exhibit growth were serially diluted and
plated on TSA for CFU counting. The minimal concentration
of antibiotic causing a CFU reduction of at least 3 Log10
compared to the initial inoculum was taken as the MBC European
Committee for Antimicrobial Susceptibility Testing (EUCAST)
of the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) (2000). A number of 10 CFU/mL was taken
as detection limit.
Evaluation of the Activity of AMPs,
Colistin and Daptomycin against
CCCP-Induced Persisters
The activity of three different AMPs, colistin and daptomycin
was tested against CCCP-induced persisters of P. aeruginosa
and S. aureus. Persister-enriched cultures of P. aeruginosa and
S. aureus were obtained by treatment with CCCP as described
above. CCCP-treated and untreated bacteria were diluted in
SPB/LB to a density of 1 × 106 CFU/mL and incubated in
the absence (viability control) or in the presence of different
concentrations of C5, Den-SB056 and TB_L1FK (0.435–14 µM).
Colistin (0.435–14 µM) and daptomycin (3.5–224 µM) were
assayed against CCCP-treated cells of P. aeruginosa and S. aureus,
respectively. For daptomycin testing, bacteria were diluted in
deionized water supplemented with 1% LB and 75 µg/mL CaCl2.
After 3 h of incubation at 37◦C, samples were serially diluted and
plated on TSA to determine the number of CFU.
Statistical Analysis
All experiments were performed at least in triplicate and
differences between mean values of groups were evaluated by
one-way analysis of variance (ANOVA) followed by Tukey-
Kramer post-hoc test. A p-value < 0.05 was considered
statistically significant. Data analysis was performed with
GraphPad InStat (GraphPad Software, La Jolla, CA, United
States).
RESULTS
Evaluation of the Effect of CCCP on Cell
Viability
We first assessed the susceptibility of stationary-phase cultures
of P. aeruginosa and S. aureus to CCCP in order to identify
the concentrations able to ensure maximum cell survival. As
shown in Figure 1, exposure of P. aeruginosa cultures to CCCP at
concentrations up to 200 µg/mL did not exert a significant killing
effect. In the case of S. aureus, only a minor effect on cell viability
was observed by treating cultures with CCCP at concentrations
up to 400 µg/mL.
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FIGURE 1 | Effect of CCCP on viability of P. aeruginosa ATCC 27853 (black bars) and S. aureus ATCC 33591 (gray bars). Stationary-phase cultures of P. aeruginosa
and S. aureus were exposed to different concentrations of CCCP for 3 h. Following the treatment, the number of surviving cells was evaluated by CFU counting.
Data are reported as mean ± standard error of the mean of at least three independent experiments.
FIGURE 2 | Effect of CCCP on the induction of persistence in stationary-phase cultures of P. aeruginosa ATCC 27853 (A–C) and S. aureus ATCC 33591 (D–F).
Ability of different concentrations of CCCP to induce a persister-like status was assessed by evaluating the percentage of cells surviving the treatment with
ciprofloxacin (5 µg/mL) (A) or levofloxacin (2.5 µg/mL) (D) following 3-h exposure to CCCP. Optimal exposure time to CCCP was assessed based on cell survival to
ciprofloxacin (5 µg/mL) (B) or levofloxacin (2.5 µg/mL) (E) following a pretreatment of 1 or 3 h with CCCP at 200 µg/mL (for P. aeruginosa) or 400 µg/mL (for
S. aureus). Susceptibility of P. aeruginosa to meropenem (10 µg/mL) (C) and S. aureus to gentamicin (10 µg/mL) (F) was determined following a pretreatment of 3 h
with CCCP. Data are reported as mean ± standard error of the mean of at least three independent experiments. ∗∗p < 0.01; ∗∗∗p < 0.001 (one-way ANOVA
followed by Tukey-Kramer post hoc test).
Generation of PCs of P. aeruginosa and
S. aureus by CCCP Treatment
The optimal concentration of CCCP and exposure time required
for the induction of persistence in stationary-phase cultures
of P. aeruginosa and S. aureus were established based on the
acquisition of tolerance to antibiotics following the treatment
with CCCP. Indeed, the lack of specific markers for persistence
makes antibiotic tolerance the only reliable evidence of the
persister status (Brauner et al., 2016). Two fluoroquinolones,
ciprofloxacin (5 µg/mL) and levofloxacin (2.5 µg/mL), were
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FIGURE 3 | Global metabolic activity of CCCP-induced persisters of P. aeruginosa ATCC 27853 (A,B) and S. aureus ATCC 33591 (C,D). Metabolic activity was
evaluated by measuring in real time bacterial heat production through isothermal microcalorimetry for 24 h. Controls (CTRLs) represent CCCP-untreated
stationary-phase cultures. Representative data of two independent experiments are reported.
initially used to assess the acquisition of antibiotic tolerance
in CCCP-pretreated cells of P. aeruginosa and S. aureus,
respectively. When these antibiotics were used against bacteria
in the absence of CCCP pretreatment, only a very low
percentage of the initial population survived antibiotic exposure
(Figures 2A,D). In particular, less than 0.01% of stationary-
phase cultures of P. aeruginosa survived ciprofloxacin exposure
(Figure 2A), while approximately 0.5% of the initial inoculum
of S. aureus tolerated levofloxacin treatment (Figure 2D),
in accordance with the presence of naturally occurring PCs
within the cultures. Interestingly, the percentage of bacteria
surviving antibiotic treatment markedly increased in a dose-
dependent manner following CCCP pretreatment. In the case
of P. aeruginosa, cultures pretreated with CCCP at 200 µg/mL
for 3 h showed a 5000-fold increase in the number of persister-
like cells as compared to the untreated control (Figure 2A).
In the case of S. aureus, the highest percentage of persister-
like cells was obtained by pretreating cultures with CCCP at
400 µg/mL. Indeed, after a 3-h pretreatment, approximately
60% of the initial population survived levofloxacin exposure
(Figure 2D). Furthermore, a time-dependent increase in the
number of persister-like cells emerged from the evaluation of the
antibiotic susceptibility of both bacterial species following a pre-
incubation of 1 or 3 h with the identified optimal concentrations
of CCCP. Indeed, a 3-h exposure to CCCP produced a statistically
significant increase in the survival rate of P. aeruginosa and
S. aureus to fluoroquinolones as compared to a pretreatment of
1 h (Figures 2B,E).
The ability of CCCP to induce persistence was confirmed
by exposing CCCP-pretreated cultures to antibiotics with a
different mechanism of action than fluoroquinolones, namely
the β-lactam meropenem and the aminoglycoside gentamicin
against P. aeruginosa and S. aureus, respectively. As shown
in Figures 2C,F, stationary-phase cultures pretreated with
CCCP for 3 h exhibited a significantly increased tolerance
to meropenem and gentamicin as compared to the untreated
controls. In particular, treatment of P. aeruginosa cultures with
CCCP at 200 µg/mL determined a 200-fold increase in the
percentage of bacteria tolerant to meropenem (35% of the
starting bacterial population) (Figure 2C). Analogously, survival
of S. aureus cultures to gentamicin increased by approximately
500 times upon exposure to CCCP at 400 µg/mL, resulting in
20% of the cells becoming persisters (Figure 2F).
Since a 3-h exposure to CCCP at 200 and 400 µg/mL resulted
to be efficient in the induction of a persister-like status in
P. aeruginosa and S. aureus respectively, these optimal conditions
were adopted for the generation of persister-enriched cultures in
all the subsequent experiments.
Analysis of the Metabolic Activity of
CCCP-Induced Persisters
Global metabolic activity of CCCP-treated cells of P. aeruginosa
and S. aureus was quantitatively assessed in real time by
isothermal microcalorimetry, a highly sensitive technique that
allows to monitor microbial metabolic activity in the presence
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FIGURE 4 | Oxidoreductase activity of CCCP-induced persisters of P. aeruginosa ATCC 27853 (A) and S. aureus ATCC 33591 (B). Oxidoreductase activity of
CCCP-pretreated cells was assessed through cytofluorimetric analysis after staining of the bacteria with the fluorogenic dye Redox Sensor Green (RSG). Controls
(CTRLs) represent CCCP-untreated stationary-phase cultures. Representative data of two independent experiments are reported.
or absence of growth-inhibiting compounds through the
measurement of heat production over time (Braissant et al.,
2010; Di Luca et al., 2017). As shown in Figure 3, untreated
stationary-phase cultures of both P. aeruginosa and S. aureus
released heat over the time resulting in typical heat flow patterns.
On the contrary, only a basal heat production was observed
(<5 µWh) when both bacterial species were incubated with
CCCP, suggesting an overall decrease in the metabolic activity of
CCCP-treated cells.
The effect of CCCP treatment on bacterial oxidoreductase
activity was assessed through cytofluorimetric analysis after
staining of the cells with the fluorogenic dye RSG. RSG has
been recently reported to be a convenient indicator of metabolic
activity at the single cell level since it provides a stable green
fluorescent signal when reduced by bacterial reductases in
metabolically active cells (Orman and Brynildsen, 2013; Orman
et al., 2016). In the case of both P. aeruginosa (Figure 4A) and
S. aureus (Figure 4B), a 3-h exposure to CCCP determined a
reduction of approximately three times in RSG fluorescence as
compared to the untreated control, indicating a drop in bacterial
oxidoreductase activity following CCCP treatment.
Evaluation of the Revival of
CCCP-Induced Persisters
When incubated in a nutrient-rich environment, PCs have been
shown to exhibit a characteristic lag phase before resumption of
normal growth (Balaban et al., 2004; Gefen et al., 2008). Hence,
in order to confirm further that CCCP pretreatment induced
persistence, we evaluated the time required for the revival of
the cultures upon removal of CCCP and exposure to fresh
nutrients. The presence and duration of a time lag were initially
determined by monitoring bacterial heat production through
isothermal microcalorimetry. In the case of both P. aeruginosa
(Figure 5A) and S. aureus (Figure 5C), identical heat flow
patterns were obtained for CCCP-pretreated and untreated
cultures. Nevertheless, CCCP-pretreated cells were characterized
by a delay in heat production as compared to the untreated
controls. Time of maximum heat production was extrapolated
from the heat flow plots in order to determine the exact delay
in the recovery of CCCP-pretreated bacteria. In this respect, a
time lag of 1.5 h was recorded for CCCP-pretreated cultures
of P. aeruginosa (Figure 5A), while a 1-h delay was observed
in the case of S. aureus (Figure 5C). Similar results were also
obtained when the revival was evaluated by measuring bacterial
growth by optical density. Indeed, CCCP-induced persisters of
both bacterial species displayed a lag phase of approximately 1 h
before resuming replication at a normal rate (Figures 5B,D).
Susceptibility of CCCP-induced persisters to different classes
of antibiotics was determined after the revival in order to
verify the reversion of bacteria to a normal, antibiotic-sensitive
phenotype. To this aim, the progeny of both CCCP-pretreated
and untreated cells was harvested at early exponential growth
phase and exposed to ciprofloxacin, gentamicin, levofloxacin or
meropenem for the evaluation of the MIC and MBC values. As
reported in Table 2, CCCP-pretreated and untreated cultures of
both P. aeruginosa and S. aureus exhibited the same MIC and
MBC values for each of the tested antibiotics, indicating that the
loss of CCCP effect correlated with the sensitization to the action
of antibiotics at the prior treatment levels.
Evaluation of the Anti-persister Activity
of AMPs and Conventional
Peptide-Based Antibiotics
The antimicrobial activity of three structurally different AMPs
(Table 1) was determined by CFU counting against persister-
enriched cultures of P. aeruginosa and S. aureus generated
by CCCP treatment. Under the same experimental conditions,
the anti-persister activity of the polypeptide colistin and the
lipopeptide daptomycin was also assessed against CCCP-induced
persisters of P. aeruginosa and S. aureus, respectively. In the case
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FIGURE 5 | Revival of CCCP-induced persisters of P. aeruginosa ATCC 27853 (A,B) and S. aureus ATCC 33591 (C,D). Time required for the revival of
CCCP-induced persisters was determined by measuring bacterial heat production through isothermal microcalorimetry (A,C) and by monitoring bacterial growth by
optical density (B,D) after the removal of CCCP and re-suspension of bacterial cells in fresh LB. CCCP-untreated bacteria incubated in fresh culture medium were
used as controls (CTRLs). Representative data of two independent experiments are reported.
TABLE 2 | MIC and MBC values of ciprofloxacin, gentamicin, levofloxacin and
meropenem against CCCP-pretreated and CCCP-untreated bacteria after their
revival in fresh culture medium.
CCCP-untreated CCCP-pretreated
MIC MBC MIC MBC
P. aeruginosa Ciprofloxacin 0.5a 1 0.5 1
Meropenem 10 10 10 10
S. aureus Levofloxacin 0.5 0.5 0.5 0.5
Gentamicin 20 40 20 40
aConcentrations are expressed in µg/mL.
of both P. aeruginosa (Figure 6A) and S. aureus (Figure 6B), all
three AMPs eradicated persister-enriched cultures to the limit of
detection (10 CFU/mL) at concentrations ranging from 1.75 to
14 µM. Colistin displayed a bactericidal activity against CCCP-
pretreated cells of P. aeruginosa at levels comparable to AMPs
and determined the complete killing of the starting bacterial
inoculum at concentrations as low as 3.5 µM (Figure 6A). On
the contrary, a markedly reduced anti-persister activity against
S. aureus was observed in the case of daptomycin, which exerted
its bactericidal effect only at concentrations 32 to 64-fold higher
than those of the tested AMPs (Figure 6B).
The susceptibility of CCCP-induced persisters to AMPs,
colistin and daptomycin was compared to that of CCCP-
untreated bacteria in terms of MBC values. As shown in
Table 3, all tested AMPs and colistin exerted a bactericidal effect
against CCCP-pretreated bacteria at levels comparable to those
of CCCP-untreated bacteria. Indeed, the majority of the tested
AMPs exhibited the same MBCs toward CCCP-pretreated and
untreated cells of both P. aeruginosa and S. aureus. In the case of
colistin, only a 2-fold increase in the MBC value against CCCP-
pretreated bacteria of P. aeruginosa was recorded. Conversely,
in the case of daptomycin, a 16-fold higher concentration was
required to kill CCCP-induced persisters of S. aureus than that
effective against untreated bacteria.
DISCUSSION
Over the last years, the importance of PCs in chronic
and relapsing infections has been increasingly recognized
and a growing body of research has focused on finding
alternative strategies for the eradication of antibiotic tolerant
bacteria. Several innovative approaches have been suggested
for the elimination of PCs, including their reversion to a
metabolically active and antibiotic-susceptible state through
exposure to chemical compounds such as the fatty acid cis-2-
decenoic acid and the quorum sensing inhibitor (Z)-4-bromo-5-
(bromomethylene)-3-methylfuran-2(5H)-one (Kim et al., 2011;
Pan et al., 2012; Marques et al., 2014). Considerable attention has
been devoted to the identification of antimicrobial agents with
a growth-independent mechanism of action in order to target
both actively dividing cells and PCs. Indeed, eradication of entire
bacterial populations is mandatory to avoid the relapse of the
infection and minimize the chance of resistance development
during prolonged antibiotic treatments (Zhang, 2014). In this
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FIGURE 6 | Activity of AMPs and peptide-based antibiotics against
CCCP-induced persisters of P. aeruginosa ATCC 27853 (A) and S. aureus
ATCC 33591 (B). Anti-persister activity of C5, Den-SB056, TB_L1FK, colistin
or daptomycin was evaluated by CFU counting after 1.5 h incubation with
CCCP-pretreated cultures. Dashed lines indicate a reduction of 3 Log10 in the
number of CFU of the starting inoculum. A number of 10 CFU/mL was taken
as detection limit. Data are reported as mean ± standard error of the mean of
at least three independent experiments.
regard, Conlon et al. (2013) have recently proposed a mechanism
of persister killing based on activation of Clp protease and
dysregulation of proteolysis by acyldepsipeptide-4 (ADEP4).
Interestingly, combining ADEP4 with rifampicin resulted in
complete eradication of S. aureus biofilms both in vitro and in
a murine model of deep-seated infection (Conlon et al., 2013).
Similarly, mitomycin C and cisplatin have been demonstrated to
be active against a broad range of PCs due to the direct cross-
linking of DNA (Kwan et al., 2015; Chowdhury et al., 2016). Anti-
persister strategies involving cationic AMPs have also emerged as
promising routes of investigation although still poorly explored.
Due to their ability to physically damage bacterial membranes,
AMPs have been proven effective in withstanding the dormant
and quiescent state of PCs (Chen et al., 2011; Briers et al., 2014;
Mohamed et al., 2016).
Although recent progress in developing alternative
therapeutic strategies against PCs is encouraging, testing
novel anti-persister molecules is often a complex process because
of the difficulty in isolating the small fraction of PCs from
the main bacterial population. Traditional isolation methods
rely on the differential response of persister and non-persister
subpopulations to antibiotic exposure, which results in typical
biphasic killing patterns. Addition of increasing concentrations
of antibiotics to bacterial cultures and/or prolonged exposure
times determine a rapid elimination of non-persisters that is
followed by a killing plateau ascribable to surviving PCs (Gefen
and Balaban, 2009; Fauvart et al., 2011). Unfortunately, due
to the low levels of naturally forming PCs, antibiotic-based
methods provide persisters with a very low efficiency (Henry
and Brynildsen, 2016). In addition, difficulties have been found
in separating the surviving persister subpopulation from the
large proportion of dead bacteria, which may interfere with the
proper assessment of the antibacterial activity of molecules with
unconventional mechanisms of action like membrane-active
AMPs. Other more sophisticated protocols aimed at PCs analysis
and isolation have been proposed (e.g., fluorescence-activated
cell sorting based methods), but they are a feasible solution only
for well-equipped laboratories (Orman and Brynildsen, 2013).
To address this issue, we sought to develop an improved
and simple method for obtaining persister-enriched cultures of
medically relevant bacteria based on the treatment with the
uncoupling agent CCCP. The ability of CCCP to induce high
levels of persistence has been previously reported for the model
organism E. coli (Kwan et al., 2013). The development of a
persister-like status in CCCP-treated cells has been linked to
the inhibition of ATP synthesis and the consequent reduction
in bacterial metabolic activity. Importantly, CCCP treatment
mimics a naturally occurring mechanism of persister formation
(i.e., ATP depletion), which has been recently demonstrated
to control persistence in both S. aureus and E. coli (Conlon
et al., 2016; Shan et al., 2017). Here we investigated the effect
of CCCP on the induction of persistence in P. aeruginosa and
S. aureus by evaluating the acquisition of antibiotic tolerance
TABLE 3 | MBC values of AMPs, colistin and daptomycin against CCCP-pretreated and CCCP-untreated cultures of P. aeruginosa ATCC 27853 and S. aureus ATCC
33591.
P. aeruginosa S. aureus
CCCP-untreated CCCP-pretreated CCCP-untreated CCCP-pretreated
C5 0.87a 0.87 0.87 0.87
Den-SB056 0.87 1.75 1.75 1.75
TB_L1FK 14 14 7 3.5
Colistin 1.75 3.5 – –
Daptomycin – – 7 112
aConcentrations are expressed in µM.
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and the metabolic activity of CCCP-treated bacteria. Different
parameters of the method were examined in order to define the
optimal concentration of CCCP and exposure time able to ensure
the maximum cell survival and to generate the highest number
of PCs. We succeeded in obtaining high-persister cultures with
only a minor effect on cell viability by treating stationary-phase
cultures of P. aeruginosa and S. aureus for 3 h with CCCP
at 200 and 400 µg/mL, respectively. Indeed, these exposure
conditions determined a substantial increase in cell survival to
the treatment with different classes of bactericidal antibiotics,
inducing a persister status in 20–60% of the initial bacterial
population. Tolerance to antibiotics was found to correlate with
a significant decrease in bacterial metabolic activity as proven
by isothermal microcalorimetry and flow cytometry. Although
isothermal microcalorimetry is not yet routinely used in the
field of microbiology, it emerged as a valuable technique for
the assessment of the persister status in bacteria as it allowed
to measure in real time bacterial metabolism in terms of heat
production. Global reduction in bacterial heat production and
low oxidoreductase activity confirmed the induction of a state
of dormancy in CCCP-treated cells. Furthermore, since the exit
of PCs from their dormant state is associated with a specific
lag phase during the resuscitation process, we also evaluated
the revival of CCCP-induced persisters upon incubation in
a nutrient-rich medium (Gefen et al., 2008; Jõers et al.,
2010). Like naturally occurring PCs, CCCP-induced persisters
displayed a typical delay before resumption of normal growth,
thus providing an additional indication of the efficiency of
CCCP in inducing persistence. When tested for susceptibility
to antibiotics, the bacterial population regrown from CCCP-
induced persisters exhibited a normal and antibiotic-sensitive
phenotype highlighting the transient nature of the induced
persister status. Additionally, reversion to the normal phenotype
allowed us to definitely characterize the antibiotic tolerance of
CCCP-treated bacteria as persistence rather than spontaneous or
CCCP-induced genetic resistance.
Persister-enriched cultures of P. aeruginosa and S. aureus
generated by CCCP treatment were employed to evaluate the
anti-persister activity of three structurally different AMPs. The
polypeptide colistin and the lipopeptide daptomycin were also
tested for their activity against PCs as a model of licensed
peptide-based antibiotics with a membrane-targeting mechanism
of action. All tested AMPs were highly effective against CCCP-
induced persisters of both bacterial species, even leading to the
complete eradication of the bacteria. Among the three peptides
tested, C5 and Den-SB056 exhibited a superior bactericidal
activity against both CCCP-treated and untreated cells as
compared to TB_L1FK, reasonably due to their higher cationic
charge and number of amino acid residues (Han et al., 2016).
In the case of membrane-active antibiotics, we found colistin
to be highly active against PCs of P. aeruginosa, in accordance
with previous studies that have reported its ability to eradicate
PCs of E. coli and to enhance the anti-persister activity of
different antibiotics (Cui et al., 2016). Conversely, daptomycin
was effective at eliminating CCCP-induced persisters of S. aureus
only at very high concentrations (Lechner et al., 2012). Based
on these observations, we were able to prove that our protocol
ensures a reliable determination of the anti-persister activity of
membrane-targeting molecules, allowing for the detection of the
bactericidal activity of both highly active and poorly effective
agents. Moreover, our results confirmed that targeting the
bacterial membrane represents a valuable strategy to eliminate
PCs. Antibiotic-tolerance of PCs can largely be explained by
the arrest in metabolic activity since conventional antibiotics
target active cellular processes like macromolecule biosynthesis.
On the contrary, membrane-targeting molecules do not require
an active metabolism to exert their bactericidal action, thus
resulting in a rapid and effective killing of both replicating cells
and non-replicating persisters (Briers et al., 2014; Cui et al.,
2016). Therefore, membrane-active molecules may represent
attractive templates for the development of novel anti-persister
agents and a suitable treatment option for persistent biofilm-
associated infections. Furthermore, the broad-spectrum anti-
persister activity of AMPs constitutes an additional advantage
of developing such molecules as anti-persister agents as they
might be able to control multispecies infections involving both
Gram-positive and Gram-negative bacteria.
CONCLUSION
In the present study, we described an improved method for the
generation of PCs based on CCCP treatment, which allowed
to obtain bacterial cultures with high levels of persisters and
only a negligible contamination from dead bacteria. Interestingly,
our protocol resulted to be valid on different bacterial species
emerging as a favorable tool for future studies on persistence and
for testing the anti-persister activity of novel molecules against
both Gram-positive and Gram-negative bacteria. Persister-
enriched cultures obtained in the study made it possible to
evaluate with sufficient accuracy the anti-persister properties of
different membrane-targeting molecules revealing their potential
as novel class of antimicrobials.
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